Elsevier Brings Together Leading Experts From Around the World for DIAMOND 2011 Conference

News provided by

Elsevier

10 Jan, 2011, 17:24 GMT

NEW YORK, January 10, 2011 /PRNewswire/ --

- Conference Will Focus on the Fields of Diamond, Diamond-like Compounds, Carbon Nanotubes, Graphene, and Nitrides

Elsevier announced today that DIAMOND 2011, 22nd European Conference on Diamond, Diamond-Like Materials, Carbon Nanotubes and Nitrides, will occur on 4-8 September 2011 in Garmisch-Partenkirchen, Bavaria, Germany. The Elsevier organized conference discusses the significant improvements in material growth processes, material purity and doping of these materials over the past few years. The improvements have lead to the discovery of new phenomena in these materials as well as to novel device applications with increasingly impressive performance levels.

The conference is now accepting abstracts for oral and paper presentations in the topics of diamond, diamond-like carbon, carbon nanotubes, graphene, and III-nitrides: growth properties and applications. Abstract submissions should be made through the online abstract submission system at http://www.diamond-conference.elsevier.com. The deadline for abstract submission is March 3, 2011.

"Elsevier is very excited to be organizing DIAMOND 2011 in collaboration with the scientific community," said Allyn Molina, Elsevier Publisher. "Building on the success of last year's conference, the program will continue to bring a broad spectrum of speakers and topics that present the current state of diamond science."

"In 2011 we expect significant progress with respect to single crystalline diamond wafer production as well as quantum effects in diamond applied for quantum computing, cryptography and magnetic field sensing," commented Christoph Nebel, conference Chair and Professor at Fraunhofer Institut fur Angewandt Festkorperphysik (IAF), Germany. "These topics are at the leading edge of semiconductor research, utilizing the unique properties of diamond for novel semiconductor applications of the near future and will be addressed at DIAMOND 2011."

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell (http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/home.url), Reaxys ( http://notice.reaxys.com/maintenance.html), MD Consult ( http://www.mdconsult.com/php/222075573-2/homepage) and Nursing Consult (http://www.nursingconsult.com/php/222075595-2/home.html), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC ( http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). 

    
    Media Contact
    Jason Awerdick
    +1-212-633-3103
    j.awerdick@elsevier.com